A "Treasure" Long Before It Was an Export

Manuka honey comes from bees foraging on Leptospermum scoparium, a flowering shrub native to New Zealand and southeast Australia. Long before it became an international wellness export, the manuka plant itself held a central place in traditional Māori medicine, where it was referred to as a "taonga," or treasure. Māori healers used crushed manuka leaves and bark in poultices for wounds, brewed the leaves into teas for digestive and respiratory complaints, used steam from boiled leaves for congestion, and chewed the bark to settle stomach upset.

Honey itself — from manuka and other native flora — was part of this broader tradition of plant-based remedies, though it was manuka's distinct, unusually strong antibacterial reputation among beekeepers that would eventually draw serious scientific attention, more than a century after European settlers arrived and began keeping European honeybees in New Zealand.

The Scientist Who Took the Folklore Seriously

That scientific attention arrived largely through the work of Dr. Peter Molan, a biochemist at the University of Waikato. Starting in the 1980s, Molan's research demonstrated that manuka honey's antibacterial activity was substantially stronger than that of ordinary honey — and, crucially, that some of that activity persisted even when the honey's hydrogen peroxide content (the antibacterial mechanism common to most honey) was neutralized. Something else in manuka honey was doing the work, and for years, nobody could say exactly what.

The 2006 Discovery That Explained It

The mystery compound turned out to be methylglyoxal, or MGO — identified in published research in 2006 as the source of manuka honey's distinctive "non-peroxide" antibacterial activity. MGO occurs in small amounts in most honey, but manuka honey contains it at concentrations far beyond typical floral honey, which explained the outsized effect Molan and others had been observing for two decades. This discovery is what led directly to today's MGO grading system, where manuka honey is now sold and priced according to its lab-tested methylglyoxal concentration rather than vague marketing claims.

It's worth being clear about what MGO research actually covers: the strongest and most consistent evidence relates to antibacterial and wound-related activity, not blood sugar specifically. Manuka honey's role in a blood-sugar-support formula like GlucoTide leans more on its broader antioxidant profile and traditional use than on direct clinical evidence tying MGO to glucose metabolism — a distinction worth understanding rather than assuming.

From New Zealand Beehives to a Modern Ingredient Label

Today, manuka honey is one of the most tightly regulated honey varieties in the world — New Zealand's Ministry for Primary Industries maintains official testing standards to prevent mislabeled or diluted product from being sold as genuine manuka. That level of scrutiny is part of why manuka honey extract shows up as a named, graded ingredient on supplement labels instead of a vague "honey" listing: its unique chemistry can actually be measured and verified, a legacy of Molan's research and the MGO discovery that followed it.

This article is for general educational purposes only and is not medical advice. Manuka honey/MGO research discussed here relates primarily to antibacterial activity, not to GlucoTide as a finished product. GlucoTide is not intended to diagnose, treat, cure, or prevent diabetes or any other disease.

See How Manuka Honey Extract Fits Into GlucoTide

Read our full ingredient-by-ingredient breakdown, including pricing and safety notes.

Read the Full GlucoTide Review →